Join the 8th World Congress of Telederm, Imaging & AI for Skin Diseases Virtually!

by The DermEngine Team on Sep 26, 2020

MetaOptima’s CEO, Dr. Maryam Sadeghi, will be speaking at the World Congress of Teledermatology, Imaging, and Artificial Intelligence for Skin Diseases

COVID-19: Teledermatology Regulatory Updates To Better Serve You

by The DermEngine Team on May 4, 2020

COVID-19 has drastically changed the way professionals are providing dermatology care. Read a summary of the most important changes to teledermatology laws

Teledermatology: Support Your Patients At Every Step

by The DermEngine Team on Apr 15, 2020

With DermEngine's onboarding plan for teledermatology, your staff and patients can get started with confidence for an accessible care solution.

COVID-19: How Can Your Practice Overcome Social Distancing?

by The DermEngine Team on Mar 17, 2020

More patients than ever need your care. How can you provide quality services when many are no longer comfortable physically attending their appointment?

MetaOptima Proudly Concludes Their First ATA19 Conference!

by The DermEngine Team on Apr 16, 2019

The MetaOptima team greatly enjoyed their first year attending the ATA19 Conference! We were happy to share insights on the power of efficient and accessible teledermatology tools that streamline practices and provide quality care to patients with evidence-based support tools.

MetaOptima Conquers Day 1 At ATA 2019!

by The DermEngine Team on Apr 15, 2019

Today was day 1 of the American Telemedicine Association Conference. Visit booth 932 to see how DermEngine’s teledermatology features best fit your needs.

How Can An Enterprise EMR Approach Benefit Dermatology Practices?

by The DermEngine Team on Feb 6, 2019

As disconnected healthcare systems continue to burden providers, medical experts are turning to an enterprise approach to standardize operational workflows. Practices are now adopting interoperable EMR software such as DermEngine with the goal of optimizing communication for higher quality care.